北欧非酒精性脂肪性肝病患者采纳地中海饮食的障碍与促进因素
在英格兰一家三级肝病中心招募19名非酒精性脂肪性肝病(NAFLD)成人,开展12周地中海饮食干预并提供行为策略,不限制热量或运动。干预后地中海饮食评分从基线7.6±2.5升至12周9.8±2.8(平均增加2.2分,P=.006),体重平均下降2.4 kg(P=.001),72%参与者高密度脂蛋白胆固醇升高(P=.009)。定性访谈识别出促进因素与障碍。
要点
- 12周地中海饮食干预后,地中海饮食评分从基线7.6±2.5升至12周9.8±2.8(平均增加2.2分,P=.006)。
- 体重平均下降2.4 kg(从基线99.2±17.0 kg降至12周96.8±17.5 kg,P=.001)。
- 72%参与者高密度脂蛋白胆固醇升高(P=.009);促进因素包括营养知识与技能、家庭支持等。
核心结论
- 在英格兰北部NAFLD患者中,12周地中海饮食干预可接受,并与体重显著下降及高密度脂蛋白胆固醇升高相关。
- 识别出的障碍与促进因素可支持适当的治疗调整并指导个性化干预方法。
研究设计与样本
- 混合方法研究,调查12周地中海饮食干预的效果及感知障碍与促进因素。
- 从英格兰一家三级肝病中心招募19名NAFLD成人。
- 通过购物清单、膳食计划和食谱教授行为策略,未给予热量配额或体育活动建议。
- 使用14分地中海饮食评估工具在基线和12周后评估膳食摄入,评分分为低(<5分)、中(6-9分)、高(10-14分)。
- 半结构化访谈录音、转录后采用框架法分析。
主要发现
- 12周后地中海饮食采纳显著增加,从moderate升至high:平均增加2.2分,从基线7.6±2.5升至12周9.8±2.8(P=.006)。
- 体重平均下降2.4 kg:从基线99.2±17.0 kg降至12周96.8±17.5 kg(P=.001)。
- 72%参与者高密度脂蛋白胆固醇升高(从基线1.10±0.8至12周1.20±1.30 vs 1.00±0.5,P=.009)。
- 促进因素包括营养知识与技能增加、家庭支持、媒体和临床环境对地中海饮食的推广以及营养护理。
- 障碍包括致肥环境、生活应激源和对便利性的需求;对NAFLD病因和意义了解不足对改变饮食习惯的准备度产生不利影响。
关键数值与推荐
- 地中海饮食评分:低(<5分)、中(6-9分)、高(10-14分)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Dietary interventions for weight loss are effective therapies for nonalcoholic fatty liver disease (NAFLD). The Mediterranean diet might benefit these patients, but it is not followed consistently in Northern European countries. We examined factors that determine Mediterranean diet adoption and maintenance in a northern European population. METHODS: We used a mixed-methods approach to investigate the effects of a 12-week Mediterranean diet intervention and perceived barriers and facilitators. Nineteen adults with NAFLD were recruited from a tertiary hepatology center in England. Participants were taught behavioral strategies through the provision of shopping lists, meal planners, and recipes; no advice was given on calorie allowances or physical activities. We used the 14-point Mediterranean diet assessment tool to assess dietary intake, based on a small number of foods in servings per day or servings per week, at baseline and after 12 weeks; participants were assigned scores of low (<5 points), moderate (6-9 points), or high (10-14 points). Semistructured interviews were audiorecorded, transcribed, and analyzed using the framework method. RESULTS: Twelve weeks after the dietary advice, Mediterranean diet adoption significantly increased from moderate to high (mean increase, 2.2 points; from 7.6 ± 2.5 at baseline to 9.8 ± 2.8 at 12 wk) (P = .006). This increase was associated with a mean reduction in body weight of 2.4 kg (from 99.2 ± 17.0 kg at baseline to 96.8 ± 17.5 kg at 12 wk) (P = .001) and increased serum concentrations of high-density lipoprotein cholesterol in 72% of participants (from 1.10 ± 0.8 at baseline to 1.20 ± 1.30 vs 1.00 ± 0.5 at 12 wk) (P = .009). Increased nutrition knowledge and skills, family support, Mediterranean diet promotion in media and clinical settings, and nutritional care facilitated diet changes. Barriers to Mediterranean diet uptake included an obesogenic environment, life stressors, and demand for convenience. Poor understanding of the causes and significance of NAFLD adversely affected readiness to change dietary habits. CONCLUSIONS: In an analysis of patients with NAFLD in the northern United Kingdom, we found a 12-week Mediterranean diet intervention was acceptable and associated with significant reductions in body weight and increased serum levels of high-density lipoprotein. We identified barriers and facilitators that could support appropriate treatment adaptations and guide personalized intervention approaches.
引用
- Haigh L, Bremner S, Houghton D, et al. Barriers and Facilitators to Mediterranean Diet Adoption by Patients With Nonalcoholic Fatty Liver Disease in Northern Europe. Clin Gastroenterol Hepatol. 2018. PMID: 30391437. doi:10.1016/j.cgh.2018.10.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。